Misleading Results With the 14-3-3 Assay for the Diagnosis of Creutzfeldt-Jakob Disease
Neurol 55:1396-1397, Chapman,T.,et al, 2000
Anti-Inflammatory Drugs Protect Against Alzheimer Disease at Low Doses
Arch Neurol 57:1586-1591, Broe,G.A.,et al, 2000
Treatment of Agitation in AD
Neurol 55:1271-1278,1247, Teri,L.,et al, 2000
Dementia with Lewy Bodies in a Neuropathologic Series of Suspected Creutzfeldt-Jakob Disease
Neurol 55:1401-1404, Haik,S.,et al, 2000
Statins and the Risk of Dementia
Lancet 356:1627-1631, Jick,H.,et al, 2000
Heroin-Induced Spongiform Leukoencephalopathy: Value of Diffusion MF Imaging
J Comput Assist Tomog 24:735-737, Chen,C.,et al, 2000
Variant Creutzfeldt-Jakob Disease in UK children: A National Surveillance Study
Lancet 356: 1224-1227, Verity,C.M.,et al, 2000
Iatrogenic Creutzfeldt-Jakob Disease at the Millenium
Neurol 55:1075-1081, Brown,P.,et al, 2000
Chorea Resulting From Paraneoplastic Striatal Encephalitis
JNNP 69:512-515, Tani,T.,et al, 2000
Systematic Review of Clinical Prediction Rules for Neuroimaging in the Evaluation of Dementia
Arch Int Med 160:2855-2862, Gifford,D.R.,et al, 2000
Linkage of Familial Amyotrophic Lateral Sclerosis with Frontotemporal Dementia to Chromosome 9q21-q22
JAMA 284:1664-1669, Hosler,B.A.,et al, 2000
Familial Occipital Calcifications, hemorrhagic Strokes, Leukoencephalopathy, Dementia, and External Carotid Dysplasia
Neurol 55:1661-1667, Iglesias,S.,et al, 2000
Rivastigmine (Exelon) for Alzheimer's Disease
The Medical Letter 42:93-94, , 2000
Magnetic Resonance Imaging in the Clinical Diagnosis of Creutzfeldt-Jakob Disease
Arch Neurol 57:1751-1757, Schroter,A.,et al, 2000
Popultaion Norms for the MMSE in the Very Old
Neurol 5:1609-1613,1601, Dufouil,C.,et al, 2000
The Value of Informant Versus Individual's Complaints of Memory Impairment in Early Dementia
Neurol 55:1724-1726, Carr,D.B.,et al, 2000
Efficacy of Rivastigmine in Dementia with Lewy Bodies: a Randomised, Double-blind, Placebo-controlled International Study
Lancet, 356:2031-2036,2024, McKeith,I.,et al, 2000
Niemann-Pick Disease Type C: Two Cases and an Update
Movement Disorders 15:1199-1203, Uc,E.Y.,et al, 2000
Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000
Clinical Criteria for the Diagnosis of Vascular Dementia, A Multicenter Study of Comparability and Interrater Reliability
Arch Neurol 57:191-196, Chui,H.C.,et al, 2000
Rethinking the Role of Tube Feeding in Patients with Advanced Dementia
NEJM 342:206-210, Gillick,M.R., 2000
Might Olfactory Dysfunction be a Marker of Early Alzheimer's Disease?
Lancet 355:84-85, Burns,A., 2000
Estrogen for Alzheimer's Disease in Women, Randomized, Double-Blind, Placebo-Controlled Trial
Neurol 54:295-301, Henderson,V.W.,et al, 2000
Autosomal Dominant Diffuse Leukoencephalopathy with Neuroaxonal Spheroids
Neurol 54:463-468, van der Knaap,M.S.,et al, 2000
The Nonmotor Problems of Parkinson's Disease
The Neurologist 6:18-27, Friedman,J.H.&Fernandez,H.H., 2000
Diffusion-Weighted MRI in Vascular Dementia
Neurol 54:83-89, Choi,S.H.,et al, 2000
Diagnosis and Treatment of Intravascular Lymphomatosis
ArchNeurol 57:374-377, Baumann,T.P.,et al, 2000
An 80-Year-Old Man With Memory Loss
JAMA 283:1046-1053, Larson,E.B., 2000
Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease
ArchNeurol 57:339-344, Fox,N.C.,et al, 2000
Diagnostic Accuracy of Dementia with Lewy Bodies
ArchNeurol 57:347-351, Hohl,U.,et al, 2000
Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease
JAMA 283:1007-1015,1055, Mulnar,R.A.,et al, 2000
Clinicopath Conf,Cerebral Amyloid Angiogpathy and Giant-Cell Inflammatory Reaction to Beta 4-Amyloid and Vasculitis, Case 10-2000
NEJM 342:957-965, , 2000
Progression of Parkinsonian Signs in Alzheimer's Disease
Neurol 54:1284-1289, Wilson,R.S.,et al, 2000
Practice Parameter: Risk of Driving and Alzheimer's Disease (An Evidence-Based Review)
Neurol 54:2205-2211, Dubinsky,R.M.,et al, 2000
The Preclinical Phase of Alzheimer Disease
Arch Neurol 57:808-813, Elias,M.F.,et al, 2000
Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000
Hypersexuality in Patients with Dementia: Possible Response to Cimetidine
Neurol 54:2024, Wiseman,S.V.,et al, 2000
The Pulvinar Sign on Magnetic Resonance Imaging in Variant Creutzfeldt-Jakob Disease
Lancet 355:1412-1418,1384, Zeidler,M.,et al, 2000
The Relative Frequency of "Dementia of Unknown Etiology" Increases With Age and Is nearly 50% in Nonagenarians
Arch Neurol 57:713-719, Crystal,H.A.,et al, 2000
Diagnosis of New Variant Creutzfeldt-Jakob Disease
Ann Neurol 47:575-582, Will,R.G.,et al, 2000
Clinicopath Conf., Pick's Disease, Case 11-2000
NEJM 342:1110-1117, , 2000
Smoking and Dementia in Male British Doctors: Prospective Study
BMJ 320:1097-1102,1087, Doll,R.,et al, 2000
Highly Active Antiretroviral Therapy for Patients with AIDS Dementia Complex: Effect on MR Imaging Findings and Clinical Course
AJNR 21:670-678, Thurnher,M.M.,et al, 2000
Variability of the Mini-Mental State Examination in Dementia
Neurol 54:1538-1539, Doraiswamy,P.M.&Kaiser,L., 2000
Progressive Dementia and Gait Disorder in a 78 Year Old Woman
JNNP 68:526-531, Tagliati,M.,et al, 2000
Survival in End-Stage Dementia Following Acute Illness
JAMA 284: 47-52, 87, Morrison,R.S. & Siu,A.L., 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000
Risk of Acquiring Creutzfeldt-Jakob Disease from Blood Transfusions: Systematic Review of Case-Control Studies
BMJ 321:17-19, Wilson,K. et al, 2000
FLAIR MRI in sporadic Creutzfeldt-Jakob Disease
Neurol 55:147-148, Vrancken,A.F.J.E. et al, 2000